Stamford, CT -- (SBWIRE) -- 01/15/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: North American Palladium Ltd (USA) (NYSEMKT:PAL),Galectin Therapeutics Inc. (NASDAQ:GALT), Generex Biotechnology Corporation (OTCMKTS:GNBT), Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN)
North American Palladium Ltd (USA) (NYSEMKT:PAL) opened the session at $0.65, trading in a range of $0.60 - $0.65. The stock showed a negative performance of -11.58% in the last trading session from its previous close of $0.69 and closed at $0.610. The stock traded on a volume of 4.68 million shares and the average volume of the stock remained 3.84 million shares. North American Palladium Ltd. (NAP) is a precious metals producer that has been operating its flagship Lac des Iles mine (LDI) located in Ontario, Canada. LDI is a primary producer of palladium. The Company is in the business of exploring and mining palladium, platinum, gold and certain base metals. The Company’s 100%-owned subsidiary is the Lac des Iles Mines Ltd. (LDI).
Has PAL Found The Bottom and Ready To Move Up? Find Out Here
Galectin Therapeutics Inc. (NASDAQ:GALT) traded 1.34 million shares in the last business day while the average volume of the stock remained 674,936 shares. The stock showed a negative movement of -10.48% to end at $12.05. The 52 week range of the stock remained $2.00 - $17.88.
Has GALT Found The Bottom And Ready To Gain Momentum? Find Out Here
Generex Biotechnology Corporation (OTCMKTS:GNBT) reported 7.83 million shares were exchanged during the last trade, while the average volume is about 5.31 million shares. The stock dropped -10.04% and finished the day at $0.0430. The beta of the stock is recorded at 2.12. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity.
Why Should Investors Buy GNBT After the Recent Fall? Just Go Here and Find Out
Ivanhoe Energy Inc. (USA) (NASDAQ:IVAN) shares dropped -8.91 percent from its previous close of $0.56 to close at $0.510. Traded with volume of 1.68 million shares in the prior session and the average volume of the stock remained 1.25 million shares. Ivanhoe Energy Inc. (Ivanhoe) is an independent international heavy oil development and production company. Ivanhoe’s core operations are in Canada, Ecuador, China and Mongolia, with business development opportunities worldwide. Ivanhoe’s wholly owned subsidiary, Sunwing Energy Ltd. (Sunwing) is focused on a natural gas exploration project (the Zitong Block) in Sichuan Province of China.
Will IVAN Get Buyers Even After The Recent Rally? Find Out Here
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Read full disclaimer at: http://www.jetlifepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)